Dr. De Blank is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
MLC 7018
Cincinnati, OH 45229Phone+1 513-517-2068Fax+1 513-636-3549
Summary
- Dr. Peter De Blank is a pediatric hematologist/oncologist in Cincinnati, OH and is affiliated with Cincinnati Children's Hospital Medical Center. He received his medical degree from University of California (San Francisco) School of Medicine and has been in practice 12 years. He specializes in pediatric neuro-oncology and is experienced in pediatric brain tumors, low-grade glioma, neurofibromatoses, and optic pathway gliomas.
Education & Training
- Children's Hospital of PhiladelphiaFellowship, Pediatric Neuro-Oncology, 2011 - 2012
- Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2008 - 2011
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2005 - 2008
- University of California San Francisco School of MedicineClass of 2005
Certifications & Licensure
- IN State Medical License 2021 - 2025
- KY State Medical License 2021 - 2025
- OH State Medical License 2012 - 2025
- PA State Medical License 2005 - 2014
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 33 citationsYears of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009.Peter de Blank, Quinn T. Ostrom, Chaturia Rouse, Yingli Wolinsky, Carol Kruchko
Cancer Medicine. 2015-04-01 - 369 citationsAlex's Lemonade stand foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007-2011Quinn T. Ostrom, Peter de Blank, Carol Kruchko, Claire M. Petersen, Peter Liao
Neuro-Oncology. 2015-01-01 - 6 citationsPhase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report.Mariko DeWire, Margot Lazow, Olivia Campagne, James Leach, Christine Fuller
Neuro-Oncology Advances. 2022-04-16
Grant Support
- St Baldrick's Scholar AwardSt. Baldrick's Foundation2014–Present
- Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational ResearchNeurofibromatosis Therapeutic Acceleration Program2014–Present
- David Mahoney Neuro-Imaging GrantDana Foundation2013–Present
- K12 Training GrantNational Institutes of Health2012–2014
- Center for Pediatric Clinical Effectiveness Pilot GrantCenter for Pediatric Clinical Effectiveness2010–2011
- T32 Training GrantNational Institutes of Health2009–2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: